Trending Now
Transactional
Kirkland & Ellis Steers $2.55 Billion CIRCOR Aerospace Acquisition For KKR
Kirkland & Ellis is steering private equity giant KKR and CIRCOR International through a $2.55 billion all-cash deal to sell CIRCOR’s aerospace division to Parker Hannifin. Backed by financial advisors Goldman Sachs and Evercore, the massive divestiture marks KKR’s fourth exit from an industrials investment this year. The carve-out arrives just three years after the buyout firm originally took the broader manufacturing entity private for approximately $1.6 billion, with the transaction scheduled to close in the second half of 2026 pending regulatory approvals...
Litigation
California Jury Clears OpenAI Executives Of Liability In Elon Musk Lawsuit
An administrative timeline defense has cleared the legal path for OpenAI to pursue its initial public offering, Yahoo Finance reported. A California jury cleared OpenAI CEO Sam Altman and President Greg Brockman of liability regarding allegations that they unjustly enriched themselves by transitioning the entity from a nonprofit to a for-profit business...
Policy
SEC Proposes Major Overhaul To Registered Offerings And Reporting Rules
The Securities and Exchange Commission has proposed a sweeping regulatory overhaul that will grant corporate issuers faster access to capital markets and drastically lower compliance hurdles. Marking the most significant structural adjustment to federal registration protocols in more than two decades, the dual rulemakings aim to reverse a decades-long decline in domestic public listings...
Features
Boston Federal Jury Hits Takeda With $885 Million Pay-For-Delay Antitrust Verdict
A federal jury in Boston has delivered a historic $885 million antitrust verdict against Takeda Pharmaceutical, marking the first trial defeat for a drugmaker in a "pay-for-delay" class-action lawsuit since a pivotal 2013 U.S. Supreme Court decision. The decision directly impacts the financial risks of pharmaceutical patent litigation, as federal antitrust law allows the initial $885 million award to be automatically tripled, elevating Takeda’s potential liability to more than $2.6 billion...




























